Advancements in Liquid Biopsy

Liquid biopsy technologies are revolutionizing cancer diagnostics by offering non-invasive, real-time insights into tumor biology. This study examines recent breakthroughs, including circulating tumor DNA (ctDNA) analysis, extracellular vesicle profiling, and the detection of circulating tumor cells (CTCs). These innovations enable earlier detection, more personalized treatment strategies, and improved monitoring of therapy effectiveness—marking a significant shift in how cancer is diagnosed and managed.